FDA approves Medtronic's Guardian Connect CGM

06:21 EDT 13 Mar 2018 | SmartBrief

Medtronic's Guardian Connect continuous glucose monitoring system was approved by the FDA for diabetes patients ages 14 to 75 -More

Original Article: FDA approves Medtronic's Guardian Connect CGM


More From BioPortfolio on "FDA approves Medtronic's Guardian Connect CGM"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...